Interrogating Real-World Case Studies in Validating Computational Models Including De Novo, Generative AI & Machine Learning to Enhance Predictability Power in Biologics Discovery & Development

Welcome to the 10th CDD for Biologics Summit

The landscape of biologics discovery is rapidly evolving, driven by breakthroughs in AI, an influx of high-quality datasets, and regulatory momentum supporting in silico approaches. As industry leaders look to streamline R&D and de-risk development, there is a critical need for cutting-edge tools in modeling, characterization, screening, and developability.

Returning to Boston this fall at this opportune moment, the 10th anniversary of the CDD for Biologics Summit will unite 50+ decision-makers and industry experts from pharma and biotech to share their unfiltered lessons learned from validating and training computational models to streamline novel target validation, enhance biologics design and empower developability predictions.

This is the go-to forum for innovators across pharma and biotech to showcase current pipeline developments that can enable faster, smarter, and more scalable therapeutic design.

Diving into the latest industry applications of computational models, including physics-based, generative AI, and de novo design across multiple large molecules, including peptides, ADCs, bispecific T-cell engagers, multi-specifics, vaccines, and more.

2025 AGENDA LIVE NOW

Expert Speaker Faculty

Frank Teets AI Proteins

Frank Teets

Head of Computational Sciences

AI Proteins

Jenna Caldwell AstraZeneca

Jenna Caldwell

Associate Principal Scientist

AstraZeneca

Joel Karpiak GlaxoSmithKline

Joel Karpiak

Senior Director, Head of Protein Design & Informatics

GlaxoSmithKline

Norbert Furtmann Sanofi

Norbert Furtmann

Group Leader & Head of Artificial Intelligence Innovation Nanobody Platform, Computational & High-throughput Protein Engineering

Sanofi

Shipra Malhotra Takeda

Shipra Malhotra

Senior Scientist - Biologics, Computational & Machine Learning

Takeda Pharmaceutical

What To Expect

Dive into Lab-in-the-loop AI validation systems for integrating experimental feedback into AI pipelines to refine de novo biologic designs in real-time

Learn how to avoid misleading conclusions by adopting statistically rigorous model performance assessments

Understand the adaptations or de novo design tools needed to predict efficacy, binding, and developability in multi-component biologics

Explore case studies highlighting where early integration of cross-functional perspectives led to more impactful outcomes

Our 2025 Partner
Ginkgo Bioworks partnership opportunity with Computational Drug Development
Companies in the Room
Sanofi - CDD for Biologics
Visterra - CDD for Biologics
IBM CDD for Biologics
AI Proteins - CDD Bio Conference
AstraZeneca - CDD Bio Conference
VRG Therapeutics - CDD Bio Conference
Eli Lilly & Co - CDD Bio Conference
AbbVie - CDD Bio Conference
Novartis - CDD Bio Conference
Amgen - CDD Bio Conference
Takeda - CDD Bio Conference
IBM CDD for Biologics
Astellas Pharma - CDD Bio Conference
AstraZeneca - CDD Bio Conference
Toyota Technological Institute at Chicago - CDD Bio Conference
The Francis Crick - CDD Bio Conference
A-Alpha Bio - CDD Bio Conference
Tectonic Therapeutic - CDD Bio Conference
Hear From Previous Attendees

"I see immense value in attending the Annual CDD for Biologics Summit. This event provides a unique opportunity to stay abreast of cutting-edge computational methods and best practices in biologics research"

Teva Pharmaceuticals

"CDD provides an opportunity to go beyond the hype of AI/ML and discuss with other practitioners in the field the details of what the technology can do today."

Adimab